Mice bearing the genomic mutation D337T on the thyroid hormone receptor b (TRb) gene present the classical signs of resistance to thyroid hormone (TH), with high serum TH and TSH. This mutant TR is unable to bind TH, remains constitutively bound to co-repressors, and has a dominant negative effect on normal TRs. In this study, we show that homozygous (TRbD337T) mice for this mutation have reduced body weight, length, and body fat content, despite augmented relative food intake and relative increase in serum leptin. TRbD337T mice exhibited normal glycemia and were more tolerant to an i.p. glucose load accompanied by reduced insulin secretion. Higher insulin sensitivity was observed after single insulin injection, when the TRbD337T mice developed a profound hypoglycemia. Impaired hepatic glucose production was confirmed by the reduction in glucose generation after pyruvate administration.
Introduction
Thyroid hormones (TH) exert profound effects on metabolism and growth. Most of TH actions occur through the nuclear TH receptors (TRs), which are ligand-dependent and ligand-independent transcription factors (Yen 2001) . TRs are encoded by two distinct genes, Thra and Thrb, located on mouse chromosomes 11 and 14 (Thompson et al. 1987 , Wood et al. 1991 . The use of alternative splicing or transcription initiation sites generates at least three TH-binding isoforms TRa1, TRb1, and TRb2. These isoforms display a distinct pattern of expression among tissues and during developmental stages (Yen 2001) . The molecular mechanism of TH action involves TR binding to TH-responsive elements on the promoter region of target genes (Forman et al. 1992 , Shibusawa et al. 2003 and the recruitment of transcriptional co-factors. These co-factors may act as co-activators, including members of the steroid receptor co-activator family (Hong et al. 1997 , Ortiga-Carvalho et al. 2005 ) and the peroxisome proliferator-activated receptor-g co-activator 1 (PGC1; Wu et al. 2002) , or co-repressors (CoR), more importantly the nuclear receptor CoR and the silencing mediator of TR and retinoic acid receptor (Ishizuka & Lazar 2003) .
Mice bearing TR mutations have been used as a tool to study TH effects in genes regulated by different TR isoforms. Here, we used mice that express the TRbD337T, which cannot bind TH, being constitutively associated with CoR and acting as a potent dominant negative inhibitor of the WT TR (Safer et al. 1998 , Pazos-Moura et al. 2000 , Hashimoto et al. 2001 ). This mouse model reproduces the human syndrome of resistance to TH (Hashimoto et al. 2001) . Because of the hypothalamic-pituitary resistance to TH, serum TSH and TH were elevated and tissues present variable degrees of resistance, depending on the type of predominant receptor and on the specific mutation (O'Shea et al. 2006) . Previous studies have shown that TRbD337T mice presented alterations in cholesterol metabolism (Hashimoto et al. 2006) and were deficient in S cone expression in the retina (Pessôa et al. 2008) .
TH effects on growth, body composition, and glucose homeostasis have been described and result from the action of TH on different tissues (Dimitriadis & Raptis 2001 , Fukuchi et al. 2002 , Bassett et al. 2007 ; however, the molecular mechanisms and the subtype of TR predominantly involved are not completely understood. Thus, the aim of this study was to investigate the consequences of the impairment of TR signaling on growth, adiposity, and glucose metabolism of mice carrying the D337T mutation on TRb.
Materials and Methods

Ethical approval
This study was approved by the ethics committee of the Health Sciences Center, Federal University of Rio de Janeiro (#IBCCF1002). Animal care and experimental protocols performed are in accordance with those stated by Drummond (2009 ) for the TRbD337T mutation, were used. Mice were generated as described previously (Hashimoto et al. 2001) . All mice were propagated in a mixed 129/C57/ BL6 background strain and direct comparisons were made with littermate controls. Animals were generated by heterozygous mating pairs and a total of 79 males were used in this study. The genotyping of tail DNA was performed by PCR using the following primers: 5 0 match ATGGGGAAATGG-CAGTGAGAG, 5 0 mismatch ATGGGGAAATGGCAGT-GACAC and 3 0 out AGCACACTCACCTGAAGACAT. Animals were accommodated at controlled room temperature (24G1 8C) and submitted to 12 h light:12 h darkness cycles, lights on at 0700 h.
For all experiments, mice were placed in cages containing four animals and fed standard chow (Bio-Tec, Rio de Janeiro, Brazil) and water made available ad libitum. Body weight (BW) and body length of animals were measured weekly from post-natal week 5 until 24. At the age of 23 weeks, mice were placed in individual cages and allowed to adapt for 5 days; after this period, daily food intake was measured for 8 days on two consecutive weeks and the same amount of chow was offered every 24 h, food waste was weighted. Killing was performed on 26-week-old mice by asphyxiation in CO 2 chamber after 5 h of food restriction, unless otherwise stated. After killing, trunk blood was collected and glycemia was measured by a glucometer (Optium, MediSense, Maidenhead, Berkshire, UK), and serum was obtained after centrifugation and frozen at K20 8C for measurement of serum hormones.
Abdominal (inguinal, perigonadal, and retroperitoneal) white adipose tissue (WAT) and brown adipose tissue (BAT) were excised and weighed. Interscapular BAT was identified by its anatomical location and macroscopic characteristics, and care was taken in order to dissect it from surrounding WAT. Whole pituitary and liver samples were collected and frozen at K70 8C for RNA extraction.
Body composition analysis
Body composition (fat and protein masses) analysis was determined by carcass method, previously described (Souza et al. 2009 ). Briefly, frozen eviscerated and weighed carcasses were autoclaved and homogenized in distilled water (1:1 w/v). Proteins were extracted from 1 g homogenates using potassium hydroxide and total protein was quantified using the Bradford method (Bradford 1976) . Homogenate (3 g) was used to determine fat mass gravimetrically. Samples were hydrolyzed with potassium hydroxide and ethanol, and, after the addition of sulfuric acid, total lipids were extracted by three successive washes with petroleum ether. The samples were dried at room temperature until constant weight was obtained. Both data were expressed as grams of protein or fat per 100 g carcass.
Serum thyroxine, tri-iodothyronine, leptin, and insulin measurements Specific RIA kits were used to measure serum leptin, insulin (Linco Research, Billerica, MA, USA), total tri-iodothyronine (T 3 ), and total thyroxine (T 4 ; MP Biomedicals, New York, NY, USA) levels. The detection limit and intraassay variation were 0 . 5 ng/ml and 3 . 2% for leptin, 0 . 1 ng/ml and 5 . 5% for insulin, 25 ng/dl and 4 . 6% for total T 3 , and 1 mg/dl and 1 . 4% for total T 4 , respectively. All samples were measured within the same assay.
Homeostasis model assessment-insulin resistance (HOMA-IR) was calculated from simultaneous measurements of serum glucose and insulin in mice under 5 h food restriction.
Glucose tolerance test
Mice were fasted for 12 h (from 1900 to 0700 h) before the test. Animals received an i.p. injection of 2 mg/g BW D-(C)-glucose (Merck) in PBS. One group of animals was used to measure the glycemia before the injection and 20, 40, 60, and 120 min after glucose administration, with blood samples obtained from venesection and glucose measured by a glucometer (Optium, MediSense). Another set of animals was killed before glucose injection at 15 and 30 min after glucose administration. Blood samples were collected from trunk and serum insulin measured by RIA.
Insulin sensitivity test
Mice were fasted for 12 h (from 1900 to 0700 h) before the test. Animals received an i.p. injection of 0 . 75 mIU/g BW of human recombinant insulin (Eli Lilly) in PBS. Glycemia was measured before the injection and 15, 30, 60, 90, and 120 min after insulin administration. Blood samples were obtained by tail vein section and glycemia was measured by a glucometer (Optium, MediSense). The animals used for this test were not used for further analysis presented in this paper. The last two protocols were adapted from Zhou et al. (2004) .
Pyruvate challenge test
After 12 h overnight fast, TRb WT/WT and TRb
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mice were injected intraperitoneally with 2 mg/g BW pyruvate (Sigma-Aldrich) dissolved in saline and blood glucose was measured before injection and 15, 30, 60, and 90 min after pyruvate administration. Blood samples were obtained from the tail vein and glycemia was measured by a glucometer (Optium, MediSense).
Liver glycogen content
Liver glycogen content was measured using a previously established protocol (Trevenzoli et al. 2010) . Briefly, 250 mg liver samples were homogenized and glycogen was extracted. Glycogen was then hydrolyzed and the resultant glucose was measured using an enzymatic colorimetric method (Glucox commercial kit, Doles, Goiás, Brazil) and compared to a glucose standard curve.
RNA analysis
Total RNA was extracted from samples by standard methodology (TRIzol Reagent; Life technologies, Invitrogen) for analysis of expression of Gh, phosphoenolpyruvate carboxykinase (Pck1), and PGC1a (Ppargc1a). Total RNA was reverse transcribed using 1 mg RNA and the Superscript III kit (Invitrogen). Real-time PCR was performed on Applied Biosystems 7500 Real-Time PCR System (Life Technologies Corp., Carlsbad, CA, USA) using SYBR Green PCR Master Mix (Applied BioSystems, Rockville, MD, USA). Primers were synthesized by Integrated DNA Technologies and were designed as follows:
0 , 36B4 primer was used as control as described previously (Machado et al. 2009 ). Samples were analyzed in duplicate and the cycle parameters were as follows: 50 8C for 2 min and 95 8C for 10 min, followed by 40 cycles at 95 8C for 15 s, 60 8C for 30 s, and 70 8C for 45 s. Product purity was confirmed by agarose gel analysis. Changes in mRNA expression were calculated from the cycle threshold, after correcting for 36B4 according to the 2 KDC t method (Livak & Schmittgen 2001) . Data are expressed as fold induction over WT control group, which was set to 1.
Statistical analysis
Data are reported as meanGS.E.M. One-way ANOVA was employed when comparisons were made for different genotypes, Two-way ANOVA was employed when comparisons were made for different genotypes along a time course, and analyses were followed by Student-Newman-Keuls multiple comparisons test for assessment of significance (GraphPad Prism; GraphPad Software Inc., La Jolla, CA, USA).
Differences were considered to be significant at P!0 . 05.
Results
As expected, TRb
D337T/D337T presented higher levels of serum T 3 compared with the other groups (TRb emerged by 14 and 16 weeks of age and persisted thereafter until killing at 26 weeks of age. Heterozygous male mice did not exhibit alterations in length or BW. In female mice, the TRb D337T mutation did not affect the BW or length (data not shown). For all the other parameters studied, female mice exhibited the same profile as males, and we here show the results obtained on males, since their alterations were more pronounced.
The reduced BW of TRb D337T/D337T mice cannot be completely justified by alterations in food intake, since even though in absolute values there was a slight reduction in food ingestion (data not shown), when corrected for BW, TRb D337T/D337T mice presented increased chow ingestion compared to 26 weeks of age ( Fig. 2A , P!0 . 05). In addition, the reduced apparent growth of TRb D337T/D337T male mice could not be associated with alterations in pituitary GH mRNA, the expression of which was similar regardless of genotype (Fig. 2B) . TRb D337T/D337T mice exhibited decreased adiposity as shown by the reduction in abdominal WAT mass (36% less than WT- Fig. 3A ) and further confirmed by the lower body fat content, determined by the carcass method ( Fig. 3B , P!0 . 01).
However, there was no significant difference in body protein content among the genotypes (Fig. 3C ). Contrary to WAT mass, BAT was enlarged in homozygous-mutant mice (P!0 . 001, Fig. 3D ). Although serum levels of leptin were similar among genotypes, when corrected for body lipid content, a relative increase was evident ( Fig. 3E and F, P!0 . 05).
We next analyzed the metabolic profile of mutant mice concerning glucose homeostasis. After 5 h of fasting, blood glucose levels were similar among different genotypes (Fig. 4A) . To maintain normal glycemia, TRb
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and TRb WT/D337T mice needed lower insulin secretion as deduced by serum levels of insulin ( Fig. 4B , P!0 . 05). The HOMA-IR, calculated as the product between serum insulin and blood glucose, was 60% lower in mice carrying the mutation, suggesting that their insulin sensitivity was increased ( Fig. 4C , P!0 . 05). This fact opposes what was seen in one study of patients with RTH where HOMA-IR was 50% elevated in patients carrying different mutations in heterozygosis (Mitchell et al. 2010) . We proceeded with the investigation on insulin sensitivity performing the glucose tolerance test and insulin sensitivity test on 12 h fasted mice (Fig. 5A-C) . TRb
displayed lower glycemia 20, 40, and 60 min after an i.p. glucose load compared with TRb WT/WT (P!0 . 05). Insulin concentrations measured 15 and 30 min after glucose load revealed that although at 15 min there is no significant differences among groups, homozygous animals failed to increase insulin levels at 30 min (Fig. 5B) , indicating that insulin concentrations reduced more rapidly as blood glucose reduced ( Fig. 5A and B) . TRb D337T/D337T mice were more sensitive to the hypoglycemic effects of insulin and some of them exhibited a severe hypoglycemia (below 20 mg/dl) 60 and 90 min after the i.p. insulin injection and had to be rescued with glucose infusion (Fig. 5C ). In case glycemia was below the detection limit (20 mg/dl), mice received an i.p. injection of glucose 2 mg/g BW D-(C)-glucose (Merck) in PBS. Heterozygous mice behaved similarly to WT on glucose tolerance test and insulin sensitivity test, leading us to exclude this group from the following evaluations.
In order to have some insight into hepatic glucose production, we evaluated liver glycogen content and the glucose generation after the administration of pyruvate, a precursor for gluconeogenesis. Hepatic glycogen content of TRb D337T/D337T mice was 70% reduced compared with controls ( Fig. 6A , P!0 . 05). TRb WT/WT mice displayed an expected increase in blood glucose concentration after pyruvate injection; on the other hand, TRb D337T/D337T mice could not reach the same glucose production rate as TRb WT/WT mice and exhibited lower blood glucose concentration 30 min after pyruvate injection (Fig. 6B) .
Since these results suggested that the gluconeogenic pathway could be impaired in mutant mice, we investigated the hepatic mRNA expression of PEPCK, a key gluconeogenic enzyme, which revealed a reduction in the enzyme mRNA levels in the liver of TRb D337T/D337T mice ( Fig. 6C , P!0 . 01) and it was accompanied by a reduction in Pgc1a liver mRNA ( Fig. 6D , P!0 . 01), which is an essential transcriptional factor involved in the regulation of gluconeogenic enzymes (Yoon et al. 2001) . , and TRb D337T/D337T male mice. Values are expressed as meanGS.E.M., nZ5-8.
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Discussion
In this study, we have demonstrated that mice carrying the D337T mutation in both alleles of the TRb presented growth impairment, decreased adiposity, and higher insulin sensitivity.
Mutations on the binding domain of TRb are found in the syndrome of TH resistance leading to high levels of serum TH and to signs and symptoms that are typical of either hyperthyroidism or hypothyroidism. Although mechanisms leading to resistance are not completely clarified and may be mutation specific, it is generally accepted that the resulting phenotype depends on the level of expression of a specific TR isoform in different tissues, and, for tissues where TRa is predominant, signs of hyperthyroidism can be found, the opposite being true for tissues where TRb is more abundant. Here, we used mice carrying a human natural mutation D337T that does not bind T 3 but still binds to DNA and to CoR (Hashimoto et al. 2001) . Although the D337T TRb has been described to have a potent dominant negative effect over the WT TR, except for 5 h fasting serum insulin, no other significant alterations were observed in heterozygous mice herein studied. Thus, the phenotype of the homozygous mice resulted either from total disruption of TRb signaling or from the very high levels of TH acting through TRa. Still, another possible mechanism is that a higher dose of the mutant TRb interferes with the TRa function or with the ability of other transcription factors to regulate gene expression. TRb D337T/D337T mice presented a reduced body length and weight despite increased food intake. Both hypo-and hyperthyroidism can lead to growth retardation through different mechanisms (O'Shea et al. 2003 , Bassett et al. 2007 . TH have potent stimulatory effects over GH and IGF1 production (Miell et al. 1993) ; however, in this study, despite high serum levels of TH, pituitary GH mRNA was not changed in TRb D337T/D337T mice. This argues against an impairment of the GH/IGF1 production as a cause of growth retardation in homozygous mice. Thus, it is possible that TRb D337T/D337T are shorter as a consequence of hyperthyroidism in bone, as seems to be the case for the PV mice, which bear a deletion in TRb that prevents T 3 binding and is a strong dominant negative mutant (O'Shea et al. 2003) . For unknown reasons, and contrary to the PV mice that showed growth delay in both genders, TRb D337T/D337T female mice did not present deficits in growth.
TRb D337T/D337T mice were also leaner, exhibiting decreased body fat mass in the presence of increased food intake. Previous data demonstrated that TRbPV mice did not present alterations in fat mass (Araki et al. 2009 ). The lower adiposity found in TRb D337T/D337T mice may be caused by increased energy expenditure, an expected effect of the high TH levels (Kim 2008) , possibly via the TRa. Future studies aiming to evaluate energy expenditure should elucidate this point. In addition, reduced fat mass may result from increased lipolysis, since the elevated TH levels can act through TRa to increase the lipolytic effect of catecholamines (Ribeiro et al. 2001) . Previous studies have demonstrated that leptin serum concentrations correlate positively with WAT mass (Licinio et al. 2007) , and that TH has the ability to inhibit leptin production (Escobar-Morreale et al. 1997 , Cabanelas et al. 2010 . However, despite the high serum TH, the mutant mice exhibited increased levels of leptin. This raises the possibility that the inhibitory action of TH on leptin secretion is mediated, in most part, by TRb. An alternative explanation for the increased serum leptin is related to the high serum , P!0 . 01. At time points 60, 90
and 120 min, mice presenting severe hypoglycemia were excluded from study.
TSH in TRb
D337T/D337T mice, since TSH has previously been reported to increase leptin secretion from WAT cell cultures (Menendez et al. 2003) . In addition, adult TRb D337T/D337T mice exhibited higher food ingestion even though serum leptin was increased, suggesting a partial resistance to the anorexigenic effect of leptin.
BATwas enlarged in TRb D337T/D337T mice, which may be due to stimulatory action of high TH levels through TRa, which enhances the adrenergic sensitivity, and is the major TR expressed in BAT (Hernandez & Obregon 1996) . In view of the important diet-induced thermogenic effect of BAT (Feldmann et al. 2009 ), this tissue hypertrophy may contribute to the leaner phenotype of TRb D337T/D337T mice, even though the TRb mutant may have impaired expression of uncoupling protein 1, which induction by T 3 has shown to be dependent mainly on TRb (Ribeiro et al. 2001) .
Normal glycemia seems to be maintained in heterozygous and homozygous mice in the presence of lower basal insulinemia after a short period of fasting (5 h), and with normal insulinemia after an overnight fast (12 h). However, TRb D337T/D337T mice presented an abrupt decrease in glycemia levels in response to insulin and recovered euglycemic levels faster after glucose load. This increased glucose tolerance was accompanied by lower serum insulin secretion at least in the first 30 min after glucose load (note area under the curve, Fig. 5B ). These data indicated that insulin was more efficient in increasing glucose utilization in homozygous mice. TH is known to increase insulininduced muscle glucose uptake and the expression of glucose transporter 4 in WAT and muscle (Weinstein et al. 1994 , Torrance et al. 1997 , Dimitriadis et al. 2006 . Therefore, hyperthyroidism in TRb D337T/D337T mice could explain the increased glucose tolerance and insulin sensitivity that, in this case, would be mediated by the TRa. However, experimental hyperthyroidism has also been associated with insulin resistance and with impaired b-cell responsiveness to the stimulatory action of glucose on insulin secretion (Fukuchi et al. 2002 , Holness et al. 2008 ). Therefore, it is possible that the phenotype of the mutant mice results from multiple alterations of the homeostasis of glucose utilization and production caused not only by hyperthyroidism but also by resistance to TH action, as seems to be the case in liver glucose metabolism.
Indeed, TRb D337T/D337T mice were unable to recover from the insulin-induced hypoglycemia, which was fatal for some mice. Liver glycogen is the first glucose resource to be utilized in an attempt to return to normoglycemia, and in TRb D337T/D337T mice, liver glycogen was reduced by 70%. Hepatic gluconeogenesis, which is necessary for recovery from hypoglycemia, was also impaired in TRb D337T/D337T mice, as demonstrated by the reduced conversion of pyruvate to glucose. The mechanism involves the lower liver expression of PEPCK, the rate-limiting enzyme for gluconeogenesis, and PGC1a, an essential transcriptional factor for hepatic gluconeogenesis (Yoon et al. 2001) . Despite the known stimulatory effect of TH over these genes' expression (Weitzel et al. 2003 , Klieverik et al. 2008 , they were not able to respond in the presence of the mutant TRb. These findings highlight the role of TRb in mediating TH effects on hepatic glucose production. The central control of hepatic glucose production is also subject to regulation by TH as was demonstrated in hyperthyroid rats that showed an increase in glucose production and resistance to insulin (Klieverik et al. 2008) . When infused centrally, TH produced and increased in plasma glucose, an effect mediated by sympathetic nerve activity in the liver (Klieverik et al. 2009 ).
The great majority of patients with the syndrome of TH resistance are heterozygous for the TRb mutation. The rare cases of homozygous presentation were very severe (Ono et al. 1991) , and cardiovascular disorders have been associated with lethality. However, in view of our data, and in spite of (squares) and TRb D337T/D337T (triangles) male mice. Hepatic glycogen was measured after 5 h of fasting. Pyruvate challenge was performed after overnight fasting. Values are expressed as mean GS.E.M., mice were 26-weeks-old, nZ5-7. * TRb WT/WT versus TRb
D337T/D337T
, P!0 . 01. PEPCK, phosphoenolpyruvate carboxykinase and PGC1, peroxisome proliferator-activated receptor-g coactivator 1.
L A SANTIAGO and others . Mutated TRb in adiposity and glucose homeostasis species differences, severe hypoglycemia due to impaired hepatic glucose production may be investigated as another contributing factor.
In conclusion, the D337T TRb mutation, associated with the syndrome of resistance to TH, resulted in reduced BWand length in male mice and metabolic alterations in both genders. Reduced fat accumulation was accompanied by an increase in food intake despite relatively higher leptin. More importantly, TRb D337T/D337T mice were more tolerant to glucose but more sensitive to the hypoglycemic effect of insulin due in part to an important deficit in hepatic glucose production.
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